Google alerts for “telomeres” posted this interesting study validating my idea that replicative senescence is at the heart of liver disease. They engineered mice to have poor telomere repair and then watched as the large cell liver histology typical in hepatitis and cirrhosis developed.
When data from the Copehnhagen City Heart Study was published in 2013, they concluded that shorter telomeres in leukocytes was not associated with increased cancer after adjusting for age but that it WAS associated with reduced survival from cancer http://jnci.oxfordjournals.org/content/105/7/459.long
In 2015, the same data looked at certain gene tendencies that promote telomere shortening and concluded that cancer survival was IMPROVED when shortening was enhanced in the telomeres.
Contradiction? Not so fast.
I was contacted last week by a client who has gotten his diabetes under control at the age of 73. He couldn’t be happier but based on his past negative experiences and his desire to maintain respectability as a partner in a prominent law firm, he doesn’t want to endorse me or TA-65 openly.
Although you may not be able to afford the $97 a month to try it, by just introducing four people to the incredible benefits of our adaptogenic nutraceutical, you could earn enough to pay for your own subscription. Everything above that would be gravy!
I have not watched the entire Blackburn interview but if you are so inclined, have at it:
She is not looking any younger but does give an account of playing with ants as a girl in Australia.
Alternatively, you could look at the other Google Alerts for today about telomeres showing that protecting them reduces aging whereas permitting telomere recombination ages them:
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness
